These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26209659)

  • 1. Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome.
    Weber D; Oefner PJ; Hiergeist A; Koestler J; Gessner A; Weber M; Hahn J; Wolff D; Stämmler F; Spang R; Herr W; Dettmer K; Holler E
    Blood; 2015 Oct; 126(14):1723-8. PubMed ID: 26209659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
    Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
    Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How's your microbiota? Let's check your urine.
    Jenq RR
    Blood; 2015 Oct; 126(14):1641-2. PubMed ID: 26429966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation.
    Weber D; Oefner PJ; Dettmer K; Hiergeist A; Koestler J; Gessner A; Weber M; Stämmler F; Hahn J; Wolff D; Herr W; Holler E
    Bone Marrow Transplant; 2016 Aug; 51(8):1087-92. PubMed ID: 26999466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics.
    Weber D; Hiergeist A; Weber M; Dettmer K; Wolff D; Hahn J; Herr W; Gessner A; Holler E
    Clin Infect Dis; 2019 Apr; 68(8):1303-1310. PubMed ID: 30124813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales.
    Farowski F; Els G; Tsakmaklis A; Higgins PG; Kahlert CR; Stein-Thoeringer CK; Bobardt JS; Dettmer-Wilde K; Oefner PJ; Vehreschild JJ; Vehreschild MJGT
    Gut Microbes; 2019; 10(2):133-141. PubMed ID: 30118620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
    Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
    Front Immunol; 2018; 9():669. PubMed ID: 29740427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
    Kikuchi M; Ueno M; Itoh Y; Suda W; Hattori M
    Nephron; 2017; 135(1):51-60. PubMed ID: 27701177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Tryptophan, Indole, and Indoxyl Sulfate in Urine Using Liquid Chromatography-Tandem Mass Spectrometry.
    Baird S; Clinton Frazee C; Garg U
    Methods Mol Biol; 2022; 2546():493-500. PubMed ID: 36127616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
    Parco S; Benericetti G; Vascotto F; Palmisciano G
    Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients.
    Konuma T; Kohara C; Watanabe E; Takahashi S; Ozawa G; Suzuki K; Mizukami M; Nagai E; Jimbo K; Kaito Y; Isobe M; Kato S; Takahashi S; Chiba A; Miyake S; Tojo A
    J Immunol; 2020 Mar; 204(6):1462-1473. PubMed ID: 32041784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation.
    Ingham AC; Kielsen K; Cilieborg MS; Lund O; Holmes S; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2019 Sep; 7(1):131. PubMed ID: 31519210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.
    Barrios C; Beaumont M; Pallister T; Villar J; Goodrich JK; Clark A; Pascual J; Ley RE; Spector TD; Bell JT; Menni C
    PLoS One; 2015; 10(8):e0134311. PubMed ID: 26241311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.
    Weber D; Jenq RR; Peled JU; Taur Y; Hiergeist A; Koestler J; Dettmer K; Weber M; Wolff D; Hahn J; Pamer EG; Herr W; Gessner A; Oefner PJ; van den Brink MRM; Holler E
    Biol Blood Marrow Transplant; 2017 May; 23(5):845-852. PubMed ID: 28232086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
    Peled JU; Devlin SM; Staffas A; Lumish M; Khanin R; Littmann ER; Ling L; Kosuri S; Maloy M; Slingerland JB; Ahr KF; Porosnicu Rodriguez KA; Shono Y; Slingerland AE; Docampo MD; Sung AD; Weber D; Alousi AM; Gyurkocza B; Ponce DM; Barker JN; Perales MA; Giralt SA; Taur Y; Pamer EG; Jenq RR; van den Brink MRM
    J Clin Oncol; 2017 May; 35(15):1650-1659. PubMed ID: 28296584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
    Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Hildebrandt GC; Granell M; Urbano-Ispizua A; Wolff D; Hertenstein B; Greinix HT; Brenmoehl J; Schulz C; Dickinson AM; Hahn J; Rogler G; Andreesen R; Holler E
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):67-74. PubMed ID: 18158963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.
    Simms-Waldrip TR; Sunkersett G; Coughlin LA; Savani MR; Arana C; Kim J; Kim M; Zhan X; Greenberg DE; Xie Y; Davies SM; Koh AY
    Biol Blood Marrow Transplant; 2017 May; 23(5):820-829. PubMed ID: 28192251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.